Trials / Completed
CompletedNCT04941027
Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,046 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The main goal of this protocol is to develop a well-phenotyped genetic biobank to identify genetic variants associated with the heterogeneous clinical presentations of Neurofibromatosis Type 1 (NF1). This will allow for improve understanding of NF1 pathogenesis and more personalized disease management. The investigators will conduct a GWAS analysis to identify common genetic risk variants associated with the development of cutaneous neurofibromas.
Conditions
Timeline
- Start date
- 2021-05-07
- Primary completion
- 2025-09-30
- Completion
- 2025-11-24
- First posted
- 2021-06-28
- Last updated
- 2025-12-02
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04941027. Inclusion in this directory is not an endorsement.